JP2012533322A5 - - Google Patents

Download PDF

Info

Publication number
JP2012533322A5
JP2012533322A5 JP2012521710A JP2012521710A JP2012533322A5 JP 2012533322 A5 JP2012533322 A5 JP 2012533322A5 JP 2012521710 A JP2012521710 A JP 2012521710A JP 2012521710 A JP2012521710 A JP 2012521710A JP 2012533322 A5 JP2012533322 A5 JP 2012533322A5
Authority
JP
Japan
Prior art keywords
expression
ibd
expression level
determining
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012521710A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012533322A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/042487 external-priority patent/WO2011011339A1/en
Publication of JP2012533322A publication Critical patent/JP2012533322A/ja
Publication of JP2012533322A5 publication Critical patent/JP2012533322A5/ja
Pending legal-status Critical Current

Links

JP2012521710A 2009-07-20 2010-07-19 クローン病のための遺伝子発現マーカー Pending JP2012533322A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22704909P 2009-07-20 2009-07-20
US61/227,049 2009-07-20
US30208410P 2010-02-05 2010-02-05
US61/302,084 2010-02-05
PCT/US2010/042487 WO2011011339A1 (en) 2009-07-20 2010-07-19 Gene expression markers for crohn's disease

Publications (2)

Publication Number Publication Date
JP2012533322A JP2012533322A (ja) 2012-12-27
JP2012533322A5 true JP2012533322A5 (enExample) 2013-09-05

Family

ID=42732741

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012521710A Pending JP2012533322A (ja) 2009-07-20 2010-07-19 クローン病のための遺伝子発現マーカー

Country Status (8)

Country Link
US (2) US20110033486A1 (enExample)
EP (3) EP2584049A3 (enExample)
JP (1) JP2012533322A (enExample)
CN (1) CN102639710A (enExample)
AU (1) AU2010276392A1 (enExample)
CA (1) CA2768711A1 (enExample)
SG (1) SG177699A1 (enExample)
WO (1) WO2011011339A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110229471A1 (en) 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
US9580752B2 (en) 2008-12-24 2017-02-28 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
US20140017711A1 (en) * 2011-03-25 2014-01-16 Cedars-Sinai Medical Center Methods of diagnosing ulcerative colitis and crohn's disease
US11242564B2 (en) * 2012-07-12 2022-02-08 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for predicting the survival time and treatment responsiveness of a patient suffering from a solid cancer with a signature of at least 7 genes
EP3639841B1 (en) 2013-03-27 2023-09-06 Cedars-Sinai Medical Center Treating fibrosis by inhibiting tl1a
CN105209643A (zh) * 2013-05-17 2015-12-30 豪夫迈·罗氏有限公司 用于诊断和治疗炎性肠病的方法
EP3022295A4 (en) 2013-07-19 2017-03-01 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
MA39804A (fr) * 2014-03-27 2017-02-01 Hoffmann La Roche Méthodes permettant le diagnostic et le traitement d'une maladie inflammatoire de l'intestin
EP3137628A4 (en) * 2014-05-02 2018-03-21 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (mruc) requiring colectomy
JP7082945B2 (ja) 2016-03-17 2022-06-09 シーダーズ―シナイ メディカル センター Ｒｎａｓｅｔ２により炎症性腸疾患を診断する方法
CN107541790B (zh) * 2016-06-24 2021-07-06 上海交通大学 一种糖基化检测的人凝集素/类人凝集素芯片及制备方法
IT201600090052A1 (it) * 2016-09-06 2018-03-06 Univ Degli Studi Padova Peptide per la diagnosi differenziale della Malattia di Crohn
CN106755293B (zh) * 2016-09-23 2020-09-04 宁波大学 一种与肺癌辅助诊断相关的lncRNA标志物及其应用
US10890579B2 (en) 2016-10-06 2021-01-12 The Research Foundation For The State University Of New York Methods and kits for detecting a fusion messenger RNA transcript or a polypeptide encoded by the fusion messenger RNA transcript
US20210005285A1 (en) * 2018-03-14 2021-01-07 Koninklijke Philips N.V. System and method using local unique features to interpret transcript expression levels for rna sequencing data
CN108893488A (zh) * 2018-06-19 2018-11-27 刘志强 一种重组质粒、dna疫苗及其制备方法和应用
WO2020232125A1 (en) 2019-05-14 2020-11-19 Prometheus Biosciences, Inc. Tl1a patient selection methods, systems, and devices
CN112578122B (zh) * 2019-09-27 2022-08-02 成都中医药大学 检测粪钙卫蛋白含量的试剂在制备畸形精子症筛查试剂盒中的用途
CN116168765B (zh) * 2023-04-25 2023-08-18 山东大学 基于改进strobemer的基因序列生成方法及系统
CN117031004B (zh) * 2023-08-09 2024-10-01 四川省医学科学院·四川省人民医院 一种检测网膜素-1的试剂在制备预测或评估ibs患者生活质量的产品中的应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
ATE144793T1 (de) 1989-06-29 1996-11-15 Medarex Inc Bispezifische reagenzien für die aids-therapie
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
WO1992020373A1 (en) 1991-05-14 1992-11-26 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
DK0527283T3 (da) 1991-08-12 1998-08-10 Nestle Sa Levnedsmiddelsammensætning
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
FI941572L (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
AU3178993A (en) 1991-11-25 1993-06-28 Enzon, Inc. Multivalent antigen-binding proteins
ATE419355T1 (de) 1992-02-06 2009-01-15 Novartis Vaccines & Diagnostic Marker für krebs und biosynthetisches bindeprotein dafür
EP0626012B1 (en) 1992-02-11 2003-07-09 Cell Genesys, Inc. Homogenotization of gene-targeting events
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
ATE149570T1 (de) 1992-08-17 1997-03-15 Genentech Inc Bispezifische immunoadhesine
US6283761B1 (en) 1992-09-08 2001-09-04 Raymond Anthony Joao Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
CA2223198A1 (en) 1997-01-14 1998-07-14 Societe Des Produits Nestle S.A. Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
DK1272647T3 (en) 2000-04-11 2014-12-15 Genentech Inc Multivalent antibodies and uses thereof
GB0130955D0 (en) 2001-12-24 2002-02-13 Cancer Res Ventures Expression system
WO2003064621A2 (en) 2002-02-01 2003-08-07 Ambion, Inc. HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
US7378239B2 (en) * 2002-06-25 2008-05-27 Index Diagnostics Ab Method of differentiating between ulcerative colitis and Crohn's disease
EP1644858B1 (en) 2003-07-10 2017-12-06 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
JP2005102694A (ja) * 2003-09-10 2005-04-21 Japan Science & Technology Agency 末梢血液細胞に示差的に発現されている遺伝子群、およびそれを用いた診断方法とアッセイ方法
EP1844158A4 (en) * 2004-12-06 2010-09-08 Univ Johns Hopkins BIOMARKER FOR INFLAMMATORY ENDURANCE
CA2658563A1 (en) * 2006-07-26 2008-01-31 Genizon Biosciences Inc. Crohn disease susceptibility gene
WO2008079406A2 (en) * 2006-12-19 2008-07-03 Genentech, Inc. Gene expression markers for inflammatory bowel disease
WO2008147869A2 (en) * 2007-05-22 2008-12-04 Centocor, Inc. Markers and methods for assessing and treating crohn's disease and related disorders
WO2008147900A2 (en) * 2007-05-22 2008-12-04 Genentech, Inc. Gene expression markers for inflammatory bowel disease
MX2010005893A (es) * 2007-11-29 2011-03-04 Genentech Inc Star Marcadores de expresion genica para enfermedad inflamatoria de intestino.
EP2562544A1 (en) * 2007-12-20 2013-02-27 InDex Diagnostics AB kits for use in the differentiation of IBD and IBS and further distinction between disease types of IBD

Similar Documents

Publication Publication Date Title
JP2012533322A5 (enExample)
JP2011509071A5 (enExample)
Marshall The PIRO (predisposition, insult, response, organ dysfunction) model: toward a staging system for acute illness
Cao et al. Role of MiRNAs in inflammatory bowel disease
JP2016507233A5 (enExample)
Zheng et al. Differential microRNA expression in human macrophages with Mycobacterium tuberculosis infection of Beijing/W and non-Beijing/W strain types
JP2012518421A5 (enExample)
HRP20170091T1 (hr) Dijagnostika interferona tip 1
Pang et al. miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma
JP2012500389A5 (enExample)
KR20160009582A (ko) 크론병과 연관된 tnfsf15와 dcr3의 변이체
JP2013178260A5 (enExample)
US20160096885A1 (en) Distinct effects of ifn-gamma and il-17 on tl1a modulated inflammation and fibrosis
JP2013505008A5 (enExample)
JPWO2019208671A5 (enExample)
WO2009042680A3 (en) Detection of mutations in acta2 and myh11 for assessing risk of vascular disease
JP2016521987A5 (enExample)
Murdaca et al. The role of skin and gut microbiome and epigenetic modifications in skin-autoimmune disorders
JP2011527575A5 (enExample)
KR20210144353A (ko) 단일세포 전사체 분석에 기반한 대장암의 예후 예측 방법
CN104450727A (zh) X-连锁低磷酸盐血症性佝偻病的致病基因及其编码蛋白质和应用
CN116004810A (zh) 一种用于预测covid-19重症风险的标志物及其应用
Meniaï et al. Putative antigenic proteins identified by comparative and subtractive reverse vaccinology in necrotic enteritis-causing Clostridium perfringens isolated from broiler chickens
JP2012524248A5 (enExample)
Chen et al. Profiling of histone 3 lysine 27 acetylation reveals its role in a chronic DSS-induced colitis mouse model